Trinity Biotech (TRIB) Income from Non-Controlling Interests (2019 - 2020)
Trinity Biotech's (TRIB) quarterly Income from Non-Controlling Interests came in at -$1.5 million in Q2 2020, up 72.86% year-on-year from -$848671.2 in Q3 2019, and up 33.98% quarter-over-quarter from -$2.2 million in Q1 2020.
Trinity Biotech (TRIB) Income from Non-Controlling Interests (2019 - 2020) Analysis & Trends
Trinity Biotech has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting -$1.5 million for Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -1.47 Mn |
| Mar 31, 2020 | -2.22 Mn |
| Jun 30, 2019 | -5.41 Mn |
| Mar 31, 2019 | -211,000.00 |